These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8632314)
1. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors. Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314 [TBL] [Abstract][Full Text] [Related]
2. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria. Martin PL; Potts AA; Sykes AM; McKenna DG J Pharmacol Exp Ther; 1993 Apr; 265(1):201-6. PubMed ID: 8474007 [TBL] [Abstract][Full Text] [Related]
3. The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. Zocchi C; Ongini E; Conti A; Monopoli A; Negretti A; Baraldi PG; Dionisotti S J Pharmacol Exp Ther; 1996 Feb; 276(2):398-404. PubMed ID: 8632302 [TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist. Barrett RJ; May JM; Martin PL; Miller JR J Pharmacol Exp Ther; 1993 Apr; 265(1):227-36. PubMed ID: 8386236 [TBL] [Abstract][Full Text] [Related]
5. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig. Martin PL; Ueeda M; Olsson RA J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010 [TBL] [Abstract][Full Text] [Related]
6. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta. Martin PL; May JM J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866 [TBL] [Abstract][Full Text] [Related]
7. A1 and A2 adenosine receptor modulation of contractility in the cauda epididymis of the guinea-pig. Haynes JM; Alexander SP; Hill SJ Br J Pharmacol; 1998 Oct; 125(3):570-6. PubMed ID: 9806342 [TBL] [Abstract][Full Text] [Related]
8. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells. Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Bruns RF; Lu GH; Pugsley TA Mol Pharmacol; 1986 Apr; 29(4):331-46. PubMed ID: 3010074 [TBL] [Abstract][Full Text] [Related]
10. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine. Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347 [TBL] [Abstract][Full Text] [Related]
11. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261. Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373 [TBL] [Abstract][Full Text] [Related]
12. A1 adenosine receptor modulation of electrically-evoked contractions in the bisected vas deferens and cauda epididymis of the guinea-pig. Haynes JM; Alexander SP; Hill SJ Br J Pharmacol; 1998 Jul; 124(5):964-70. PubMed ID: 9692782 [TBL] [Abstract][Full Text] [Related]
13. 2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. Franchetti P; Cappellacci L; Marchetti S; Trincavelli L; Martini C; Mazzoni MR; Lucacchini A; Grifantini M J Med Chem; 1998 May; 41(10):1708-15. PubMed ID: 9572897 [TBL] [Abstract][Full Text] [Related]
14. A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Clark AN; Youkey R; Liu X; Jia L; Blatt R; Day YJ; Sullivan GW; Linden J; Tucker AL Circ Res; 2007 Nov; 101(11):1130-8. PubMed ID: 17901362 [TBL] [Abstract][Full Text] [Related]
15. Identification of A1 and A2 adenosine receptors in the rat spinal cord. Choca JI; Proudfit HK; Green RD J Pharmacol Exp Ther; 1987 Sep; 242(3):905-10. PubMed ID: 3656118 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of the enantiomers of the potent and selective A1-adenosine antagonist 1,3-dipropyl-8-[2-(5,6-epoxynorbonyl)]-xanthine. Pfister JR; Belardinelli L; Lee G; Lum RT; Milner P; Stanley WC; Linden J; Baker SP; Schreiner G J Med Chem; 1997 Jun; 40(12):1773-8. PubMed ID: 9191953 [TBL] [Abstract][Full Text] [Related]
17. Study of the novel non-xanthine heterocyclic compound GU285 as a potent non-selective adenosine receptor antagonist in the rat. Harden FA; Brown L; Quinn RJ; Harrison GJ; Headrick JP; Rose'Meyer RB; Willis RJ Arzneimittelforschung; 2002; 52(3):175-81. PubMed ID: 11963644 [TBL] [Abstract][Full Text] [Related]